Cargando…

Gene interaction perturbation network deciphers a high-resolution taxonomy in colorectal cancer

Molecular subtypes of colorectal cancer (CRC) are currently identified via the snapshot transcriptional profiles, largely ignoring the dynamic changes of gene expressions. Conversely, biological networks remain relatively stable irrespective of time and condition. Here, we introduce an individual-sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zaoqu, Weng, Siyuan, Dang, Qin, Xu, Hui, Ren, Yuqing, Guo, Chunguang, Xing, Zhe, Sun, Zhenqiang, Han, Xinwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2022
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643007/ https://www.ncbi.nlm.nih.gov/pubmed/36345721 http://dx.doi.org/10.7554/eLife.81114

Ejemplares similares

Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer
por: Wang, Libo, et al.
Publicado: (2022)

Developing a taxonomy for colorectal cancer
por: Fang, Jiansong, et al.
Publicado: (2022)

Gene Expression Profile Reveals a Prognostic Signature of Non–MSI-H/pMMR Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer
por: Weng, Siyuan, et al.
Publicado: (2023)

Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options
por: Liu, Zaoqu, et al.
Publicado: (2022)

ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Immune perturbation network identifies an EMT subtype with chromosomal instability and tumor immune-desert microenvironment
por: Xu, Hui, et al.
Publicado: (2023)

Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysis
por: Xu, Hui, et al.
Publicado: (2022)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer
por: Guo, Chunguang, et al.
Publicado: (2022)

Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
por: Xu, Hui, et al.
Publicado: (2022)

Epigenetically regulated gene expression profiles recognized three molecular classifications with prognostic and therapeutic implications in bladder cancer
por: Xu, Hui, et al.
Publicado: (2023)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy
por: Zheng, Youyang, et al.
Publicado: (2022)

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1
por: Liu, Zaoqu, et al.
Publicado: (2021)

Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies
por: Liu, Zaoqu, et al.
Publicado: (2022)

Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypes
por: Zhang, Ge, et al.
Publicado: (2022)

Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application
por: Liu, Zaoqu, et al.
Publicado: (2022)

Junction Mapper is a novel computer vision tool to decipher cell–cell contact phenotypes
por: Brezovjakova, Helena, et al.
Publicado: (2019)

TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018)

Global cellular response to chemical perturbation of PLK4 activity and abnormal centrosome number
por: Tkach, Johnny M, et al.
Publicado: (2022)

Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2022)

Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes
por: Zhuang, Aojia, et al.
Publicado: (2023)

Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer
por: Dang, Qin, et al.
Publicado: (2021)

Deciphering the scalene association among type‐2 diabetes mellitus, prostate cancer, and chronic myeloid leukemia via enrichment analysis of disease‐gene network
por: Liu, Qiong, et al.
Publicado: (2019)

Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study
por: Bishnoi, Rohit, et al.
Publicado: (2019)

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2023)

Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer
por: Yan, Xuebing, et al.
Publicado: (2018)

CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown
por: Zhao, Nannan, et al.
Publicado: (2023)

Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect
por: Jia, Yanglei, et al.
Publicado: (2015)

Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers
por: Hong, Xuehui, et al.
Publicado: (2018)

Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance
por: Ren, Yuqing, et al.
Publicado: (2023)

Functional informed genome‐wide interaction analysis of body mass index, diabetes and colorectal cancer risk
por: Xia, Zhiyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8apmjv1vf46k1tqbhseq8ealjv